Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1673599 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Parathyroid Hormone 1 Receptor (PTH1R) (C-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the C-terminal of human PTH1R, identical to the related mouse and rat sequences.Immunogen affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.
- Handling
- Avoid repeated freezing and thawing.
Submitted references PTHR1 loss-of-function mutations in familial, nonsyndromic primary failure of tooth eruption.
Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway.
Novel mutations in the parathyroid hormone (PTH)/PTH-related peptide receptor type 1 causing Blomstrand osteochondrodysplasia types I and II.
Decker E, Stellzig-Eisenhauer A, Fiebig BS, Rau C, Kress W, Saar K, Rüschendorf F, Hubner N, Grimm T, Weber BH
American journal of human genetics 2008 Dec;83(6):781-6
American journal of human genetics 2008 Dec;83(6):781-6
Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway.
Wang B, Yang Y, Friedman PA
Molecular biology of the cell 2008 Apr;19(4):1637-45
Molecular biology of the cell 2008 Apr;19(4):1637-45
Novel mutations in the parathyroid hormone (PTH)/PTH-related peptide receptor type 1 causing Blomstrand osteochondrodysplasia types I and II.
Hoogendam J, Farih-Sips H, Wÿnaendts LC, Löwik CW, Wit JM, Karperien M
The Journal of clinical endocrinology and metabolism 2007 Mar;92(3):1088-95
The Journal of clinical endocrinology and metabolism 2007 Mar;92(3):1088-95
No comments: Submit comment
No validations: Submit validation data